Showing results (241-250 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Role of interleukin-1 in 4-hydroperoxycyclophosphamide toxicity to bone marrow progenitor cells: a reviewJ Moreb, J R ZucaliBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Decreased plasma superoxide scavenging activity in immunological disorders--carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisoloneL Prónai, S ArimoriBiotherapy (Dordrecht, Netherlands)|January 1, 1990
Successful treatment for perinephric abscess with recombinant human granulocyte colony-stimulating factor following nephrectomy in a patient of myelodysplastic syndrome: a case reportK Tamura, M Takeuchi, N Hirakawa, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1997
The incidence and clinical significance of antibodies to interferon-a in patients with solid tumorsK Oberg, G AlmBiotherapy (Dordrecht, Netherlands)|January 1, 1997
In vivo and in vitro effects of Sizofiran on the human neutrophils and the serum opsonic activityT Kumae, Y Saburi, M NasuBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditionsF Omori, S Okamura, K Shimoda, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapyY Nio, T Shiraishi, M Tsubono, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J FinnBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432H Yamaue, H Tanimura, T Tsunoda, et al.Pageof 33